Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.
Trial locations(2 sites)
United States
MD Anderson Cancer Center, Houston, Texas The University of Texas Health Science Center at Houston, Houston, Texas